Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for blood loss reduction in femoral fixation surgery
IRCT20171030037093N18Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in femoral fracture (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Hemoglobin level, Bleeding rate and 1 more. Started Oct 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20171030037093N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N18.